ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Hydrazine → 6-[(3,5-Dimethyl-1H-pyrazol-4-yl)methyl]-1-isobutyl-3-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-5-carboxylic acid

HRID 131564
印刷

反応式

HRID 131564 の反応式
[C:1](=[O:4])([O-])[O-:2].[K+].[K+].ClC1N=C(C)N([CH2:14][C:15]2[S:30][C:18]3[N:19]([CH2:26][CH:27]([CH3:29])[CH3:28])[C:20](=[O:25])[N:21]([CH3:24])[C:22](=[O:23])[C:17]=3[C:16]=2C(N2C[C@H](O)CO2)=O)C=1Cl.[CH3:40][C:41](=O)[CH2:42][C:43](=O)[CH3:44].[NH2:47][NH2:48]>ClCCl.O.C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.Cl[Co]Cl>[CH3:40][C:41]1[C:42]([CH2:14][C:15]2[S:30][C:18]3[N:19]([CH2:26][CH:27]([CH3:28])[CH3:29])[C:20](=[O:25])[N:21]([CH3:24])[C:22](=[O:23])[C:17]=3[C:16]=2[C:1]([OH:2])=[O:4])=[C:43]([CH3:44])[NH:48][N:47]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 4

HCID 9321HydrazineHCID 11430Potassium CarbonateHCID 31261AcetylacetoneHCID 101425596-[(4,5-Dichloro-2-methyl-1H-imidazol-1-yl)methyl]-5-[4-(S)-hydroxy-2-isoxazolidinylcarbonyl]-3-methyl-1-(isobutyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione

生成物 1

HCID 161028626-[(3,5-Dimethyl-1H-pyrazol-4-yl)methyl]-1-isobutyl-3-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-5-carboxylic acid

試薬・触媒・溶媒 3

HCID 432080Dichlorocobalt;triphenylphosphane触媒HCID 962Water溶媒HCID 6344Dichloromethane溶媒

実験手順

Potassium carbonate (3.55 g) and dichlorobis(triphenylphosphine)cobalt(II) (0.1 g) were added to a stirred solution of the product of example 3, part a) (1 g) and 2,4-pentanedione (2.64 ml) in dichloromethane (30 ml) under nitrogen. After 48 h, aqueous hydrazine (35%, 2.33 ml) was added and the mixture stirred vigorously for 1 h, diluted with water (30 ml) and extracted with ethyl acetate (2×60 ml). Organic extracts were dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure. The residue was purified by column chromatography over silica, eluting with ethyl acetate. The product was dissolved in tetrahydrofuran (20 ml) and methanol (3 ml) then treated with sodium hydroxide solution (1M, 2.57 ml). After 3 days, the mixture was evaporated under reduced pressure to ca. 5 ml, diluted with water (25 ml) and extracted with ethyl acetate (25 ml). The aqueous phase was acidified with hydrochloric acid and extracted with ethyl acetate (3×25 ml). Organic extracts were dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure to give the sub-title compound as a solid (0.23 g). MS(ESI) 391 [M+H]+. δ 1HDMSO 0.85 (6H, d), 2.05-2.18 (1H, m), 2.08 (6H, s), 3.17 (3H, s), 3.62 (2H, d), 3.71 (2H, s).

後処理

  1. extractionextracted with ethyl acetate (2×60 ml)
  2. dry with materialOrganic extracts were dried over anhydrous magnesium sulfate
  3. filtrationfiltered
  4. customevaporated under reduced pressure
  5. customThe residue was purified by column chromatography over silica
  6. washeluting with ethyl acetate
  7. dissolutionThe product was dissolved in tetrahydrofuran (20 ml)
  8. additionmethanol (3 ml) then treated with sodium hydroxide solution (1M, 2.57 ml)
  9. waitAfter 3 days
  10. customthe mixture was evaporated under reduced pressure to ca. 5 ml
  11. additiondiluted with water (25 ml)
  12. extractionextracted with ethyl acetate (25 ml)
  13. extractionextracted with ethyl acetate (3×25 ml)
  14. dry with materialOrganic extracts were dried over anhydrous magnesium sulfate
  15. filtrationfiltered
  16. customevaporated under reduced pressure

出典と根拠

ORDレコード
ord-9c8fb6b28cef4f168075a6b66820ef60
出典データセット
uspto-grants-2008_06
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07384950B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート